Silence Therapeutics (SLN) Intangibles (2018 - 2026)

Silence Therapeutics has disclosed Intangibles across 9 years of filings, most recently posting $248000.0 for Q1 2026.

• Intangibles for Q1 2026 came in at $248000.0, down 20.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $248000.0 (down 20.0% YoY), and the FY2025 annual result was $288000.0, down 7.69% from the prior year.
• Intangibles came in at $248000.0 for Q1 2026 at Silence Therapeutics, down from $288000.0 in the prior quarter.
• In the past five years, Intangibles ranged from a high of $375337.1 in Q4 2022 to a low of $248000.0 in Q1 2026.
• The 5-year median for Intangibles is $311000.0 (2024), against an average of $312853.0.
• Across the five-year window, Intangibles jumped 114.18% in 2022 and decreased 20.0% in 2026, its largest moves.
• Silence Therapeutics' Intangibles stood at $375337.1 in 2022, then slipped by 6.09% to $352487.1 in 2023, then dropped by 11.49% to $312000.0 in 2024, then retreated by 7.69% to $288000.0 in 2025, then decreased by 13.89% to $248000.0 in 2026.
• The last three Intangibles figures came in at $248000.0 (Q1 2026), $288000.0 (Q4 2025), and $300000.0 (Q3 2025), per Business Quant data.